Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biosimilars: The Next Big Thing
Zacks
Saturday, January 14, 2012 - 12:30pm
tags:
biosimilars
Say Yes to Novartis
Barron's
Saturday, January 14, 2012 - 12:29pm
tags:
Novartis
Otsuka Pharmaceutical and UCB focus collaboration in the area of Central Nervous System (CNS) disorders
Pipeline Review
Saturday, January 14, 2012 - 12:21pm
tags:
Cimzia, Otsuka, UCB Pharmaceuticals
3 Good Undervalued Bio-Pharma Speculation Buys
Seeking Alpha
Saturday, January 14, 2012 - 12:19pm
tags:
Ampio Pharmaceuticals, Geron, Antares Pharma
Novo Nordisk: Increasing Diabetes Rate Should Benefit This Danish Pharmaceutical
Seeking Alpha
Saturday, January 14, 2012 - 12:17pm
tags:
Novo Nordisk, diabetes
BioDelivery Science: A Pipeline Rejuvenated
Seeking Alpha
Saturday, January 14, 2012 - 12:13pm
tags:
BioDelivery Sciences
Sales of Lipitor Are Leveling Off
New York Times
Saturday, January 14, 2012 - 12:11pm
tags:
Pfizer, Lipitor, generics
Keeping An Eye On Isis
Seeking Alpha
Saturday, January 14, 2012 - 12:08pm
tags:
Isis Pharmaceuticals, antisense, proteomes
Nestle Said to Vie With Danone in Bids to Acquire Pfizer’s Baby-Food Unit
Bloomberg
Saturday, January 14, 2012 - 11:57am
tags:
Pfizer
Novartis Excedrin recall expands into Canada
Yahoo/AP
Saturday, January 14, 2012 - 11:56am
tags:
Novartis, Excedrin, recalls
J&J Marketed Risperdal to Kids Despite Warnings, Jurors Told
Bloomberg
Saturday, January 14, 2012 - 11:55am
tags:
JNJ, Risperdal
Ventrus Announces Publication of Prior Phase 2b Study on the Safety and Efficacy of Iferanserin in the Treatment of Hemorrhoid Disease
Yahoo/Globe NewsWire
Saturday, January 14, 2012 - 11:54am
tags:
Ventrus, iferanserin, hemorrhoids
The Best Big Pharma Dividend
Motley Fool
Saturday, January 14, 2012 - 11:53am
tags:
Eli Lilly, Merck, Bristol-Myers Squibb
Bristol-Myers Raised Inhibitex Offer 30%
Bloomberg
Saturday, January 14, 2012 - 11:40am
tags:
Bristol-Myers Squibb, Inhibitex, M&A
The Magic Formula for Biotech
Motley Fool
Saturday, January 14, 2012 - 11:38am
tags:
Biogen Idec to Report Fourth Quarter & Year End 2011 Financial Results on January 31, 2012
Yahoo/BusinessWire
Saturday, January 14, 2012 - 11:36am
tags:
Biogen
CEO Gaffe of the Week: Bristol-Myers Squibb
Motley Fool
Saturday, January 14, 2012 - 11:35am
tags:
Bristol-Myers Squibb, Inhibitex, M&A
7 Large-Cap Biotech Equities With Strong Momentum Right Now
Seeking Alpha
Saturday, January 14, 2012 - 11:32am
tags:
Amgen, Ariad Pharmaceuticals, Biogen, Celgene, Gilead Sciences, Vertex Pharmaceuticals
Idenix Seeks Partner for Hepatitis C Combination Drug, CEO Renaud Says
Bloomberg
Saturday, January 14, 2012 - 11:28am
tags:
Idenix, hepatitis C, IDX184
Biotechs: Has The Law Of Gravity Been Suspended?
Seeking Alpha
Saturday, January 14, 2012 - 11:27am
tags:
Celgene, Dendreon, Medivation, Regeneron, ViroPharma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.